A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults

Exclusion Criteria

• •Use of prescription or nonprescription drugs and dietary and herbal supplements within 14 days or 5 half-lives (whichever is longer) prior to the first dose of study intervention
• •Prior use of epigenetic modifying agents
• •Current use of any prohibited concomitant medication(s) or unwillingness or inability to use a required concomitant medication(s)
• •Additionally, current use or anticipated need for food or drugs that are known strong inducers or inhibitors of CYP2C9 or CYP3A4, including their administration within 14 days or 5 half-live of the strong inducers or inhibitors of CYP2C9 or CYP3A4, whichever is longer, prior to first dose of study intervention, during the treatment period, and within 2 days after the last dose of PF-07248144
• •Proton pump inhibitors must be discontinued at least 5 days prior to the first dose of study medication and throughout treatment period.